Login / Signup

Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial.

Fernando Comunello SchacherAnnelise Martins Pezzi da SilvaLucia Mariano da Rocha SillaMario Reis Álvares-da-Silva
Published in: Canadian journal of gastroenterology & hepatology (2021)
BM-MSC infusion is safe and feasible in patients with ACLF Grades 2 and 3.
Keyphrases
  • liver failure
  • hepatitis b virus
  • low dose
  • double blind
  • clinical trial